Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer - Wikidata - awgldk - TriplyDB

Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer

Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer

http://www.wikidata.org/entity/Q28291617

about

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer Signalling pathways implicated in early mammary gland morphogenesis and breast cancer.Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma CK1epsilon is required for breast cancers dependent on beta-catenin activity.Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer.The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis.ER and PR signaling nodes during mammary gland development.DNA methylation in ductal carcinoma in situ of the breast.Epigenomics and breast cancer Breast cancer-initiating cells: insights into novel treatment strategies.Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikis Hedgehog signalling in breast cancer.MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation density.Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers.MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.Tumour supressor secreted frizzled related protein 1 regulates p53-mediated apoptosis.

P2860

Q21260388-32211550-1D87-4517-A58A-07BBCE062A65 Q22000774-CF950294-861B-410C-81CE-F860C9CB018A Q24309483-F9FF7964-8810-41F1-955D-F8E08C59CE10 Q24319970-8C244D71-D9FD-4390-8A6C-82FE8814209B Q33255332-FF809738-6EF1-4A42-B7EF-17163EDB5B47 Q33290638-54B1ACE0-F3D4-4B70-9DE4-DD9A29EBB0A1 Q33620584-A85107C0-FD9F-4A6A-B8D0-3C08658903F2 Q33627196-60888B4E-76F3-49BB-85A0-AA62D7D3BFC2 Q33739319-31013AD8-63FF-4CB6-BAE5-663975F8E3C8 Q34018681-557E0BBF-3A8F-454A-90E5-56ED1FD3EC38 Q34154767-2A7CF25C-ADC0-41ED-B798-0E6CD6391FF8 Q34988570-8B80786A-421B-46AE-8DC4-42D25FBD12A5 Q35488978-48729F0E-C8A5-4DFD-9377-848D8565C114 Q36510089-5F5A3319-6087-4247-95DC-29CFFFA2CD4A Q36593641-30BA8D3D-5D29-4A03-AE12-0FC8672651C0 Q36924384-F3ED5713-BC26-4473-BFE2-5B77754C12D9 Q36998647-DBC45251-A4A4-429E-A1C4-404267D61F58 Q37078784-DFAD1D2F-2C4B-45CD-9FD7-D37D93CEC79D Q37129899-ADC9F44C-95CD-41B5-89D7-B5336AA3B0AE Q37204692-2AC22079-E6C8-4366-B378-98ECED1059C4 Q37214195-48366FC4-736F-4943-BFFD-3B9ED56C7FB2 Q37312974-B5D52175-D79F-4FAA-B9AF-DA5168FCDCD9 Q37469714-E0BCB5BE-4A44-4F9B-9203-C85B4AECA42D Q37592077-8B1887F8-8EF0-411D-A8C0-771EBC4BE401 Q40747141-84A8B986-967A-4BBD-8280-F3269F40BE1B Q49544302-CCEF3176-170A-48BC-BEE8-53E5F9090188 Q54408874-4A65A15B-A60E-42DD-ABD7-B656A4974979

P2860

Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer

http://www.wikidata.org/entity/Q28291617

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Epigenetic suppression of secr ...... ression in human breast cancer

@ast

Epigenetic suppression of secr ...... ression in human breast cancer

@en

Epigenetic suppression of secr ...... ression in human breast cancer

@nl

type

label

Epigenetic suppression of secr ...... ression in human breast cancer

@ast

Epigenetic suppression of secr ...... ression in human breast cancer

@en

Epigenetic suppression of secr ...... ression in human breast cancer

@nl

prefLabel

Epigenetic suppression of secr ...... ression in human breast cancer

@ast

Epigenetic suppression of secr ...... ression in human breast cancer

@en

Epigenetic suppression of secr ...... ression in human breast cancer

@nl

P1433

Q28291617-43CEB38E-B90D-416E-9484-905E293A65E7

P1476

Q28291617-E5A70D54-75CD-48CF-B767-E4B5C1AADF8A

P2093

Q28291617-13F597A3-1EF4-44A4-876F-9EFDA4353A2E

Q28291617-20B838FB-7513-4D47-A316-12ECF0B97251

Q28291617-40EEEECD-BB05-49A8-AA09-05998BC9D0CB

Q28291617-4CC5DF46-D20C-44DA-BC39-9DC5C66F0191

Q28291617-881ACB53-78C2-4EAF-A059-E55FCD7710FE

Q28291617-BE857474-EA15-475E-92DB-1537770D7D56

Q28291617-DA61FA8B-DC23-4512-9AF6-6C1FAC6DA503

P304

Q28291617-E5BA1FCC-2587-4502-A75A-C24BABC4E937

P31

Q28291617-18994A50-C10D-4B7A-959E-CD31BD8A65A2

P3181

Q28291617-CC3A76B3-7CB9-4A33-A99F-14CAAD7D9ADF

P356

Q28291617-B77AE20B-775F-498E-9C37-2DF09831B665

P407

Q28291617-EB43F0DB-24DF-4E1D-9FDF-E6DF289FFE7E

P433

Q28291617-8F2D2228-E3FB-4FD2-9465-AB27E1757172

P478

Q28291617-8EFD251F-989C-4C60-B827-CF3904A64CD2

P577

Q28291617-F6EBBC3E-4C10-48F7-BE65-6876B9CA11ED

P5875

Q28291617-018836F5-2F93-4ADF-9C34-36C4CB562267

P698

Q28291617-486B73C1-965F-4483-8B1A-992386508FC5

P3181

P356

P1433

Cancer Biology and Therapy

P1476

Epigenetic suppression of secr ...... ression in human breast cancer

@en

P2093

Anisha D'Costa

http://www.w3.org/2001/XMLSchema#string

Elizabeth Garrett-Mayer

http://www.w3.org/2001/XMLSchema#string

Jyoti Mehrotra

http://www.w3.org/2001/XMLSchema#string

Mary Jo Fackler

http://www.w3.org/2001/XMLSchema#string

Pang-Kuo Lo

http://www.w3.org/2001/XMLSchema#string

Pedram Argani

http://www.w3.org/2001/XMLSchema#string

Saraswati Sukumar

http://www.w3.org/2001/XMLSchema#string

P304

281-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2499877

http://www.w3.org/2001/XMLSchema#string

P356

10.4161/CBT.5.3.2384

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7360954

http://www.w3.org/2001/XMLSchema#string

P698

16410723

http://www.w3.org/2001/XMLSchema#string